BEKSAÇ, B. Et Al. 2023. Comparison of Dipeptidyl Peptidase-4 Inhibitor-Induced Bullous Pemphigoid and “Conventional” Bullous Pemphigoid: A Retrospective Study of Clinical and Laboratory Characteristics. 32nd EADV Congress , (Berlin, Germany).

BEKSAÇ, B., TEMİRKAYNAK, M. K., Gharehdagi, S., Ateşci, E., KUBAT, G., ERDEM, Ö., ... İLTER, N.(2023). Comparison of Dipeptidyl Peptidase-4 Inhibitor-Induced Bullous Pemphigoid and “Conventional” Bullous Pemphigoid: A Retrospective Study of Clinical and Laboratory Characteristics . 32nd EADV Congress, Berlin, Germany

BEKSAÇ, BURCU Et Al. "Comparison of Dipeptidyl Peptidase-4 Inhibitor-Induced Bullous Pemphigoid and “Conventional” Bullous Pemphigoid: A Retrospective Study of Clinical and Laboratory Characteristics," 32nd EADV Congress, Berlin, Germany, 2023

BEKSAÇ, BURCU Et Al. "Comparison of Dipeptidyl Peptidase-4 Inhibitor-Induced Bullous Pemphigoid and “Conventional” Bullous Pemphigoid: A Retrospective Study of Clinical and Laboratory Characteristics." 32nd EADV Congress , Berlin, Germany, 2023

BEKSAÇ, B. Et Al. (2023) . "Comparison of Dipeptidyl Peptidase-4 Inhibitor-Induced Bullous Pemphigoid and “Conventional” Bullous Pemphigoid: A Retrospective Study of Clinical and Laboratory Characteristics." 32nd EADV Congress , Berlin, Germany.

@conferencepaper{conferencepaper, author={BURCU BEKSAÇ Et Al. }, title={Comparison of Dipeptidyl Peptidase-4 Inhibitor-Induced Bullous Pemphigoid and “Conventional” Bullous Pemphigoid: A Retrospective Study of Clinical and Laboratory Characteristics}, congress name={32nd EADV Congress}, city={Berlin}, country={Germany}, year={2023}}